Gregory J. Galvin, Ph.D.
President, Chief Executive Officer and Chairman of the Board of DirectorsView Bio
Dr. Galvin has been at the forefront of multidisciplinary technology commercialization since 1993, when he launched Kionix Inc. to commercialize a novel micro-electro-mechanical system (MEMS) technology platform. Dr. Galvin sold the Kionix telecommunications platform to Calient Networks Inc. in 2000 and purchased the rights to the name and access to certain markets in 2001. Dr. Galvin continued his successful commercialization of Kionix with applications in MEMS technology for semiconductor applications including a highly successful accelerometer product for smartphones. Dr. Galvin spun out Rheonix Inc. from Kionix in 2008 to capitalize on non-MEMS-based microfluidic opportunities in the molecular diagnostics industry and sold the second incarnation of Kionix Inc. to Rohm Co. Ltd.
Dr. Galvin is a member of several scientific societies, has published more than 20 technical papers and holds 58 patents. He is a member of the Advisory Councils of the Cornell Engineering College, Entrepreneurship at Cornell and the Cornell Materials Science Department and has served as a member of the Cornell Board of Trustees. He also serves as a director of the Boyce Thompson Institute for Plant Research, the El Portal de Belén Foundation and Ithaca's Sciencenter. He was named Cornell Entrepreneur of the Year 2014.
He holds a B.S. from the California Institute of Technology in electrical engineering and a Ph.D. in materials science and MBA from Cornell University.
Peng Zhou, Ph.D.
Chief Scientific Officer and Senior Vice President of Research & DevelopmentView Bio
Prior to joining Rheonix Inc., Dr. Zhou was director of microfluidics for Kionix Inc., where he led the effort to develop the company’s microfluidic technologies, framed the microfluidic intellectual property position for long-term growth and directed external collaborations. He also spearheaded new drug discovery and development technology at both Bristol-Myers Squibb Company and Sepracor Inc., and developed proprietary technology while a scientist at Arris Pharmaceuticals.
Dr. Zhou received his Ph.D. and M.A. in chemistry from Columbia University and a B.S. in chemistry from Jilin University in China. He has published more than 20 papers and holds 31 patents in the areas of combinatorial chemistry, drug discovery instrumentation and microfluidic chip fabrication and applications.
Christopher Smith, CPA
Chief Financial Officer and Vice President of AdministrationView Bio
Mr. Smith joined Rheonix Inc. in 2010 as chief financial officer and vice president of administration, bringing with him 25 years of public and private industry experience in finance, accounting and operations with both startups and high-growth manufacturers. Prior to joining Rheonix, he served as corporate controller of Kionix Inc. from its early development stage through its exponential growth, highlighted by the 2009 acquisition by Rohm Co. Ltd. of Japan for $233 M. During his tenure with Kionix, he was actively involved in the company’s financing, the spin-off of the company’s microfluidics division into Rheonix Inc., and the due diligence associated with the Rohm transaction. Mr. Smith also served as the CFO for BinOptics, a manufacturer of semiconductor lasers for the telecom and datacom industries, where he was instrumental in guiding that company to profitability, and was actively involved in the acquisition of BinOptics by Macom for $230 M.
Mr. Smith holds a B.S. in accounting from Le Moyne College and is a member of the American Institute of Certified Public Accountants.
Richard Montagna, Ph.D., FACB
Senior Vice President for Scientific and Clinical AffairsView Bio
Dr. Montagna has over 35 years of corporate leadership experience and has managed the commercialization of over 40 biotechnology products, including FDA-approved diagnostics. He has published more than 40 scientific papers, holds a number of patents in the biosensor area, and has been awarded over $8.5 million in grant funding. He is an adjunct professor in the Department of Biological and Environmental Engineering at Cornell University and is a Fellow of the National Academy of Clinical Biochemists.
In 1988, he was invited to testify before President Reagan's Presidential AIDS Commission, providing data in support of a recommendation that the U.S. initiate mandatory screening of its donated blood supply for the presence of antibodies to HTLV-1, a human retrovirus related to the AIDS virus. Nationwide testing was implemented soon thereafter. In 2008 he was nominated for a National Research Discovery Award and is frequently invited to speak at international meetings.
Dr. Montagna earned a Ph.D. in molecular biology from the University of Buffalo and served post docs at the New York University Medical Center, as a National Institutes of Health (NIH) Fellow in Experimental Pathology and at the University of Texas M.D. Anderson Cancer Center in the area of chemical carcinogenesis.
Executive Vice President of SalesView Bio
Mr. Salky’s sales experience spans over 30 years in consumer electronics, semiconductors and medical devices. Mr. Salky joined Rheonix in 2015 as vice president of sales for applied markets and is responsible for launching and selling innovative molecular testing solutions for food and beverage pathogens and spoilage organisms. Previously, Mr. Salky was the executive vice president of sales and marketing at Kionix Inc. Mr. Salky helped drive sales of the Kionix MEMS inertial sensor in domestic and international markets. Prior to joining Kionix, Mr. Salky enjoyed a highly successful career in consumer electronics as the U.S. vice president of sales and marketing for Jiangsu Shinco Technology Co. Ltd.
Vice President of Intellectual Property and LicensingView Bio
Mr. Brenner joined Kionix Inc. in 2007 as vice president of microfluidics, prior to the formation of Rheonix. Prior to this, he was a senior technology manager at Cornell University’s technology licensing office, CCTEC, where he managed commercialization of drug delivery, diagnostic devices, food science and other analytical inventions developed by Cornell’s research faculty. Mr. Brenner was the founder and president of Aureus Inc., specializing in financial and organizational solutions for technology-based companies. Mr. Brenner is a longtime member of the Licensing Executives Society and a Certified Licensing Professional.
He holds a B.S. in plant science from the University of New Hampshire, an M.S. in science education from Syracuse University and an MBA from Cornell University.
Vice President of EngineeringView Bio
Mr. Olsen joined Rheonix Inc. in 2015 as vice president of engineering. He has previously served in senior level positions within engineering and program management with Fortune 500 companies in the in vitro diagnostics market. Mr. Olsen was the senior project manager at Hologic, where he managed cross-functional project teams working on the development and deployment of new product features. In addition, he was a program manager, leading multiple cross-functional product development teams globally and managing both assay and system product development at Siemens Healthcare Diagnostics, Life Technologies Applied Biosystems and Fluidigm Corporation. He also served as director of engineering at Life Technologies, where he managed a department in the advanced technologies and systems division. He has a proven record of driving the development and commercialization of market-leading biotechnology and medical device instrumentation, software and assay products.
Mr. Olsen studied mechanical engineering at the University of New Haven and holds a B.S. in engineering management from DeVry University.
Vice President of Strategy and MarketingView Bio
Brooke Schwartz is a business leader with over 20 years of strategy and business development experience in life sciences, food and agriculture. Prior to joining Rheonix, she assisted clients in the food, beverage and environmental testing market with development, commercialization and adoption of new technologies. She previously led Life Technologies’ global Food and Environmental Testing business, and has held leadership roles in marketing and strategy at Applied Biosystems, Deloitte Consulting and Monsanto Company. Ms. Schwartz serves as past Chair of the AOAC Research Institute.
Ms. Schwartz holds an M.B.A from the Harvard Business School and an M.S. in Food and Resource Economics from the University of Florida.